Tocilizumab and Rituximab Have Similar Effectiveness and Are Both Superior to a Second Tumour Necrosis Factor Inhibitor (Tnfi) in Rheumatoid Arthritis Patients Who Discontinued a First Tnfi
AuthID
P-00Q-Y2G
P-00Q-Y2G